Astera Labs, INC. (ALAB) — SEC Filings

Q: What are the key financial highlights for Astera Labs, INC.?

Key financial highlights for Astera Labs, INC. are extracted from the most recent 10-K or 10-Q filings, including revenue, net income, EPS, debt-to-equity, cash position, and operating margin.

Q: Who are the key executives at Astera Labs, INC.?

Key executives at Astera Labs, INC. are identified from SEC filings including 10-K annual reports, proxy statements, and insider trade forms.

Q: What are the main risk factors for Astera Labs, INC. stock?

Risk factors for Astera Labs, INC. (ALAB) are assessed from SEC filings using AI analysis. Each filing is categorized as high, medium, or low risk based on disclosed risk factors and financial indicators.

Q: What are recent predictions and forward guidance from Astera Labs, INC.?

Forward-looking statements and predictions from Astera Labs, INC. are extracted from SEC filings including earnings reports, annual reports, and current event filings.

Latest SEC filings for Astera Labs, INC.. Recent 144 filing on Apr 1, 2026. AI-decoded analysis of earnings, risk factors, and insider trades.

View Astera Labs, INC. on SEC EDGAR

Overview

Astera Labs, INC. (ALAB) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 144 filed on Apr 1, 2026: On April 1, 2026, Astera Labs, Inc. (Subject) filed a Form 144, indicating a proposed sale of securities. The filing was made by Alba Manuel, with a mailing address at 2345 North First Street, San Jose, CA 95131. The company is incorporated in Delaware and operates in the Semiconductors & Related De

Sentiment Summary

Across 34 filings, the sentiment breakdown is: 1 bullish, 32 neutral, 1 mixed. The dominant filing sentiment for Astera Labs, INC. is neutral.

Filing Type Overview

Astera Labs, INC. (ALAB) has filed 3 144, 6 10-Q, 14 8-K, 1 DEF 14A, 1 10-K, 4 SC 13G, 1 SC 13G/A, 3 S-1/A, 1 S-1 with the SEC between Feb 2024 to Apr 2026.

Filings by Year

2026 · 2025 · 2024

Recent Filings (34)

144 Filing — 144 · Apr 1, 2026
Astera Labs Files Form 144 for Proposed Securities Sale — 144 · Apr 1, 2026 Risk: medium
On April 1, 2026, Astera Labs, Inc. (Subject) filed a Form 144, indicating a proposed sale of securities. The filing was made by Alba Manuel, with a mailing add
144 Filing — 144 · Apr 1, 2026
Astera Labs Doubles Revenue, Swings to Profit Amid AI Boom — 10-Q · Nov 5, 2025 Risk: medium
Astera Labs, Inc. (ALAB) demonstrated robust financial performance for the three and nine months ended September 30, 2025, significantly improving from the prio
8-K Filing — 8-K · Nov 4, 2025
Astera Labs Files 8-K — 8-K · Oct 22, 2025 Risk: low
Astera Labs, Inc. filed an 8-K on October 22, 2025, reporting other events and financial statements. The filing does not disclose specific new material events o
Astera Labs Revenue Soars 105% on AI Demand, Net Loss Widens — 10-Q · Aug 6, 2025 Risk: medium
Astera Labs, Inc. reported a significant increase in revenue for the three and six months ended June 30, 2025. Revenue for the second quarter of 2025 surged to
Astera Labs Files 8-K on Financials — 8-K · Aug 5, 2025 Risk: low
Astera Labs, Inc. filed an 8-K on August 5, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and e
Astera Labs Files 8-K on Shareholder Votes — 8-K · Jun 10, 2025 Risk: low
Astera Labs, Inc. filed an 8-K on June 10, 2025, reporting on matters submitted to a vote of security holders as of June 5, 2025. The filing details the company
Astera Labs Files Q1 2025 10-Q — 10-Q · May 7, 2025 Risk: low
Astera Labs, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information for the first quarter of 2025, including balance
Astera Labs Files 8-K on Financials — 8-K · May 6, 2025 Risk: low
Astera Labs, Inc. filed an 8-K on May 6, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhi
Astera Labs Files Definitive Proxy Statement for 2025 Annual Meeting — DEF 14A · Apr 24, 2025 Risk: low
Astera Labs, Inc. filed its definitive proxy statement (DEF 14A) on April 24, 2025, for its annual meeting on June 5, 2025. The filing concerns the solicitation
Astera Labs Files 8-K: Director Changes & Officer Compensation — 8-K · Mar 3, 2025 Risk: low
Astera Labs, Inc. filed an 8-K on March 3, 2025, reporting on the departure of a director, election of a new director, and compensatory arrangements for certain
Astera Labs Files 2024 10-K — 10-K · Feb 14, 2025 Risk: medium
Astera Labs, Inc. filed its 2024 10-K on February 14, 2025, reporting on its fiscal year ending December 31, 2024. The company, incorporated in Delaware, operat
Astera Labs Files 8-K on Financials — 8-K · Feb 10, 2025 Risk: low
Astera Labs, Inc. filed an 8-K on February 10, 2025, reporting on its results of operations and financial condition. The filing includes financial statements an
Astera Labs Signs Material Definitive Agreement — 8-K · Dec 20, 2024 Risk: medium
Astera Labs, Inc. entered into a Material Definitive Agreement on December 16, 2024. The filing does not disclose the specific details of this agreement, only t
SC 13G Filing — SC 13G · Nov 19, 2024
SC 13G Filing — SC 13G · Nov 19, 2024
SC 13G Filing — SC 13G · Nov 14, 2024
SC 13G/A Filing — SC 13G/A · Nov 12, 2024
Astera Labs Files Q3 2024 10-Q — 10-Q · Nov 5, 2024 Risk: medium
Astera Labs, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported its financial performance for the third quarter of 2024, detaili
Astera Labs Files 8-K on Financials — 8-K · Nov 4, 2024 Risk: low
Astera Labs, Inc. filed an 8-K on November 4, 2024, reporting on its results of operations and financial condition. The filing includes financial statements and
Astera Labs Files Q2 2024 10-Q — 10-Q · Aug 7, 2024 Risk: medium
Astera Labs, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported financial results for the second quarter and the first half of 2024.
Astera Labs Files 8-K on Financials and Operations — 8-K · Aug 6, 2024 Risk: medium
Astera Labs, Inc. filed an 8-K on August 6, 2024, reporting on its results of operations, other events, and financial statements. The filing details the company
Astera Labs Appoints Semiconductor Veteran Michael R. Marks to Board — 8-K · Jun 24, 2024 Risk: low
Astera Labs, Inc. announced on June 23, 2024, the appointment of Dr. Michael R. Marks as a Class III Director, effective immediately. Dr. Marks brings extensive
Astera Labs, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 8, 2024 Risk: medium
Astera Labs, Inc. (ALAB) filed a Quarterly Report (10-Q) with the SEC on May 8, 2024. Astera Labs, Inc. filed a 10-Q report for the period ending March 31, 2024
Astera Labs Files 8-K on Financials — 8-K · May 7, 2024 Risk: low
Astera Labs, Inc. filed an 8-K on May 7, 2024, reporting on its results of operations and financial condition. The filing includes financial statements and exhi
Astera Labs Files 8-K Report — 8-K · May 3, 2024 Risk: low
On April 30, 2024, Astera Labs, Inc. filed an 8-K report to disclose information regarding other events and financial statements. The filing does not contain sp
SC 13G Filing — SC 13G · Apr 10, 2024
Astera Labs Files 8-K: Equity Sales, Governance Changes — 8-K · Mar 28, 2024 Risk: medium
On March 22, 2024, Astera Labs, Inc. filed an 8-K report detailing several key events. The company announced unregistered sales of equity securities, indicating
Astera Labs, Inc. Files Amendment No. 3 to Form S-1 Registration Statement — S-1/A · Mar 18, 2024 Risk: low
Astera Labs, Inc. (ALAB) filed a Amended IPO Registration (S-1/A) with the SEC on March 18, 2024. Astera Labs, Inc. filed an amendment (No. 3) to its Form S-1 r
Astera Labs, Inc. Files Amendment No. 2 to S-1 Registration Statement — S-1/A · Mar 8, 2024 Risk: low
Astera Labs, Inc. (ALAB) filed a Amended IPO Registration (S-1/A) with the SEC on March 8, 2024. Astera Labs, Inc. filed an amendment (No. 2) to its S-1 registr
Astera Labs Files Amendment to S-1 Registration Statement — S-1/A · Mar 1, 2024 Risk: low
Astera Labs, Inc. (ALAB) filed a Amended IPO Registration (S-1/A) with the SEC on March 1, 2024. Astera Labs, Inc. filed an amendment (S-1/A) to its registratio
Astera Labs, Inc. Files S-1 Registration Statement — S-1 · Feb 21, 2024 Risk: medium
Astera Labs, Inc. (ALAB) filed a IPO Registration (S-1) with the SEC on February 21, 2024. Astera Labs, Inc. has filed an S-1 registration statement with the SE

Risk Profile

Risk Assessment: Of ALAB's 26 recent filings, 0 were flagged as high-risk, 11 as medium-risk, and 15 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Financial Highlights

Key financial metrics from Astera Labs, INC.'s most recent 10-Q filing (Nov 5, 2025):

Revenue: $581,942 thousand
Net Income: $174,152 thousand
EPS: $0.97
Debt-to-Equity: 0.10
Cash Position: $140,407 thousand
Operating Margin: 18.3%
Total Assets: $1,401,182 thousand
Total Debt: $129,451 thousand

Key Executives

Alba Manuel
Dr. Michael R. Marks
Jitendra Mohan

Industry Context

Astera Labs operates in the rapidly evolving intelligent connectivity solutions market, crucial for high-performance computing, AI, and machine learning applications. The industry is characterized by intense competition, rapid technological advancements, and a growing demand for specialized hardware and software to manage data flow efficiently. Key players are investing heavily in R&D to develop next-generation interconnect technologies.

Top Tags

8-k (6) · financial-reporting (6) · Astera Labs (5) · IPO (5) · Semiconductors (4) · 10-Q (4) · semiconductors (4) · Emerging Growth Company (4) · corporate-governance (3) · Registration Statement (3)

Key Numbers

Revenue for Q3 2025: $230,575 thousand — Increased 103.9% from $113,086 thousand in Q3 2024
Net income for Q3 2025: $91,114 thousand — Turnaround from a net loss of $7,593 thousand in Q3 2024
Revenue for nine months ended Sept 30, 2025: $581,942 thousand — More than doubled from $255,194 thousand in the same period of 2024
Net income for nine months ended Sept 30, 2025: $174,152 thousand — Reversed a net loss of $108,134 thousand in the same period of 2024
Cash and cash equivalents as of Sept 30, 2025: $140,407 thousand — Increased from $79,551 thousand at Dec 31, 2024
Net cash provided by operating activities for nine months ended Sept 30, 2025: $224,041 thousand — Significant increase from $96,973 thousand in the same period of 2024
Research and development expenses for Q3 2025: $78,928 thousand — Increased from $50,659 thousand in Q3 2024, reflecting continued investment
Shares outstanding as of Oct 31, 2025: 168,903,616 — Indicates total common stock shares
SEC File Number: 001-41979 — Identifies the company's filing with the SEC.
IRS Employer Identification No.: 82-3437062 — Tax identification number for the company.
Q2 2025 Revenue: $52.3M — 105% increase from Q2 2024 revenue of $25.5 million
Six-Month 2025 Revenue: $98.7M — 98% increase from six-month 2024 revenue of $49.8 million
Q2 2025 Net Loss: $15.1M — Widened from a net loss of $10.2 million in Q2 2024
Revenue Concentration: 18% — Percentage of Q2 2025 revenue from a single customer
Cash and Cash Equivalents: $550.4M — As of June 30, 2025, indicating strong liquidity

Related Companies

ASTL · NVDA · AMD · MRVL · SMCI · AVGO

Frequently Asked Questions

What are the latest SEC filings for Astera Labs, INC. (ALAB)?

Astera Labs, INC. has 34 recent SEC filings from Feb 2024 to Apr 2026, including 14 8-K, 6 10-Q, 4 SC 13G. Each filing includes an AI-generated plain-English summary.

What is the overall sentiment of ALAB filings?

Across 34 filings, the sentiment breakdown is: 1 bullish, 32 neutral, 1 mixed. The dominant sentiment is neutral.

Where can I find Astera Labs, INC. SEC filings explained simply?

ReadTheFiling provides AI-powered plain-English summaries of all Astera Labs, INC. (ALAB) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.

What are the key financial highlights for Astera Labs, INC.?

Key financial highlights from Astera Labs, INC.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.

What is the investment thesis for ALAB?

The investment thesis for ALAB includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.

Who are the key executives at Astera Labs, INC.?

Key executives identified across Astera Labs, INC.'s filings include Alba Manuel, Dr. Michael R. Marks, Jitendra Mohan.

What are the main risk factors for Astera Labs, INC. stock?

Of ALAB's 26 assessed filings, 0 were flagged high-risk, 11 medium-risk, and 15 low-risk.

What are recent predictions and forward guidance from Astera Labs, INC.?

Forward guidance and predictions for Astera Labs, INC. are extracted from SEC filings as they are enriched.